-
1
-
-
0037035775
-
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
-
Howard, B. V., Rodrigues, B. L. and Bennett, P. H. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: epidemiology. 105, pp. e132-e137.
-
(2002)
, vol.105
-
-
Howard, B.V.1
Rodrigues, B.L.2
Bennett, P.H.3
-
2
-
-
0026081237
-
The epidemiology of impaired glucose tolerance and hypertension
-
Kannel, W. B., Wilson, P. W. and Zhang, T. J. (1991) The epidemiology of impaired glucose tolerance and hypertension. 121, pp. 1268-1273.
-
(1991)
, vol.121
, pp. 1268-1273
-
-
Kannel, W.B.1
Wilson, P.W.2
Zhang, T.J.3
-
3
-
-
12344282783
-
Global burden of hypertension: Analysis of worldwide data
-
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K. and He, J. (2005) Global burden of hypertension: Analysis of worldwide data. 365, pp. 217-223.
-
(2005)
, vol.365
, pp. 217-223
-
-
Kearney, P.M.1
Whelton, M.2
Reynolds, K.3
Muntner, P.4
Whelton, P.K.5
He, J.6
-
4
-
-
0035856920
-
Global and societal implications of the diabetic epidemic
-
Zimmet, P., Alberti, K. G. M. M. and Shaw, J. (2001) Global and societal implications of the diabetic epidemic. 414, pp. 782-787.
-
(2001)
, vol.414
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.M.M.2
Shaw, J.3
-
5
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
-
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T. Niklason, A. et al. (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. 353, pp. 611-616.
-
(1999)
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
Lanke, J.4
Hedner, T.5
Niklason, A.6
-
6
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
The Heart Outcomes Prevention Evaluation Study Investigators
-
The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. 342, pp. 145-153.
-
(2000)
, vol.342
, pp. 145-153
-
-
-
7
-
-
0034685403
-
Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone. The Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone. The Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). 283, pp. 1967-1975.
-
(2000)
, vol.283
, pp. 1967-1975
-
-
-
8
-
-
0034730027
-
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study
-
Hansson, L., Hedner, T., Lund-Johansen, P., Kjeldsen, S. E., Lindholm, L. H. Syvertsen, J. O. et al. (2000) Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) Study. 356, pp. 359-365.
-
(2000)
, vol.356
, pp. 359-365
-
-
Hansson, L.1
Hedner, T.2
Lund-Johansen, P.3
Kjeldsen, S.E.4
Lindholm, L.H.5
Syvertsen, J.O.6
-
9
-
-
0034729993
-
Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
-
Brown, M., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T. and Ruilope, L. M. (2000) Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). 356, pp. 366-372.
-
(2000)
, vol.356
, pp. 366-372
-
-
Brown, M.1
Palmer, C.R.2
Castaigne, A.3
de Leeuw, P.W.4
Mancia, G.5
Rosenthal, T.6
Ruilope, L.M.7
-
10
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups
-
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research groups (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 288, pp. 2981-2997.
-
(2002)
, vol.288
, pp. 2981-2997
-
-
-
11
-
-
3843080682
-
Old antihypertensives and new diabetes
-
Opie, L. H. and Schall, R. (2004) Old antihypertensives and new diabetes. 22, pp. 1453-1458.
-
(2004)
, vol.22
, pp. 1453-1458
-
-
Opie, L.H.1
Schall, R.2
-
12
-
-
29244436688
-
New onset diabetes and antihypertensive drugs
-
Mancia, G., Grassi, G. and Zanchetti, A. (2006) New onset diabetes and antihypertensive drugs. 24, pp. 3-10.
-
(2006)
, vol.24
, pp. 3-10
-
-
Mancia, G.1
Grassi, G.2
Zanchetti, A.3
-
13
-
-
0031690680
-
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
-
for the VALUE Trial Group
-
Mann, J., Julius, S. and for the VALUE Trial Group (1998) The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design. 7, pp. 176-183.
-
(1998)
, vol.7
, pp. 176-183
-
-
Mann, J.1
Julius, S.2
-
14
-
-
17844382949
-
Characteristics of 15314 hypertensive patients at high coronary risk. The VALUE Trial
-
Kjeldsen, S. E., Julius, S., Brunner, H. R., Hansson, L., Henis, M. Ekman, S. et al. (2001) Characteristics of 15314 hypertensive patients at high coronary risk. The VALUE Trial. 10, pp. 83-91.
-
(2001)
, vol.10
, pp. 83-91
-
-
Kjeldsen, S.E.1
Julius, S.2
Brunner, H.R.3
Hansson, L.4
Henis, M.5
Ekman, S.6
-
15
-
-
10744226529
-
VALUE Trial: Long-term BP trends in 13,449 patients with hypertension and high cardiovascular risk
-
for the Value Trial
-
Julius, S., Kjeldsen, S. E., Brunner, H. R., Hansson, L., Platt, F., Ekman, S. for the Value Trial et al. (2003) VALUE Trial: Long-term BP trends in 13,449 patients with hypertension and high cardiovascular risk. 16, pp. 544-548.
-
(2003)
, vol.16
, pp. 544-548
-
-
Julius, S.1
Kjeldsen, S.E.2
Brunner, H.R.3
Hansson, L.4
Platt, F.5
Ekman, S.6
-
16
-
-
2942635317
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
-
for the VALUE trial group
-
Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L. for the VALUE trial group et al. (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. 363, pp. 2022-2031.
-
(2004)
, vol.363
, pp. 2022-2031
-
-
Julius, S.1
Kjeldsen, S.E.2
Weber, M.A.3
Brunner, H.R.4
Ekman, S.5
Hansson, L.6
-
17
-
-
2942695964
-
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
-
for the VALUE trial group
-
Weber, M. A., Julius, S., Kjeldsen, S. E., Brunner, H. R., Ekman, S., Hansson, L. for the VALUE trial group et al. (2004) Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. 363, pp. 1047-1049.
-
(2004)
, vol.363
, pp. 1047-1049
-
-
Weber, M.A.1
Julius, S.2
Kjeldsen, S.E.3
Brunner, H.R.4
Ekman, S.5
Hansson, L.6
-
18
-
-
33745464829
-
Effects of valsartan compared to amlodipine on preventing type 2 diabetes mellitus in high-risk hypertensives patients: The VALUE trial
-
Kjeldsen, S. E., Julius, S., Mancia, G., McInnes, G. T., Hua, T. Weber, M. A. et al. (2006) Effects of valsartan compared to amlodipine on preventing type 2 diabetes mellitus in high-risk hypertensives patients: The VALUE trial. 24, pp. 1405-1412.
-
(2006)
, vol.24
, pp. 1405-1412
-
-
Kjeldsen, S.E.1
Julius, S.2
Mancia, G.3
McInnes, G.T.4
Hua, T.5
Weber, M.A.6
-
19
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G. de Faire, U. et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. 359, pp. 995-1003.
-
(2002)
, vol.359
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
de Faire, U.6
-
20
-
-
18544376399
-
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
-
Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Hecht Olsen, M., Wachtell, K. Dahlof, B. et al. (2002) Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. 20, pp. 1879-1886.
-
(2002)
, vol.20
, pp. 1879-1886
-
-
Lindholm, L.H.1
Ibsen, H.2
Borch-Johnsen, K.3
Hecht Olsen, M.4
Wachtell, K.5
Dahlof, B.6
-
21
-
-
48549087845
-
-
WHO. Department of Non-Communicable Disease Surveillance WHO, Geneva
-
WHO. Department of Non-Communicable Disease Surveillance (1999) pp. 1-59. WHO, Geneva
-
(1999)
, pp. 1-59
-
-
-
22
-
-
48549100521
-
Predictors of diabetes in high risk hypertensive patients in the Value Trial
-
Aksnes, T. A., Rostrup, M., Kjeldsen, S. E., Storset, Ø., Hua, A. and Julius, S. (2008) Predictors of diabetes in high risk hypertensive patients in the Value Trial.
-
(2008)
-
-
Aksnes, T.A.1
Rostrup, M.2
Kjeldsen, S.E.3
Storset, Ø.4
Hua, A.5
Julius, S.6
-
23
-
-
0037534905
-
The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial
-
for the SCOPE Study Group
-
Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B. for the SCOPE Study Group et al. (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. 21, pp. 875-886.
-
(2003)
, vol.21
, pp. 875-886
-
-
Lithell, H.1
Hansson, L.2
Skoog, I.3
Elmfeldt, D.4
Hofman, A.5
Olofsson, B.6
-
24
-
-
33749590988
-
Effect of ramipril on the incidence of diabetes
-
Bosch, J., Yusuf, S., Gerstein, H. C., Pogue, J., Sheridan, P. Dagenais, G. et al. (2006) Effect of ramipril on the incidence of diabetes. 355, pp. 1551-1562.
-
(2006)
, vol.355
, pp. 1551-1562
-
-
Bosch, J.1
Yusuf, S.2
Gerstein, H.C.3
Pogue, J.4
Sheridan, P.5
Dagenais, G.6
-
25
-
-
0025997702
-
The hemodynamic link between insulin resistance and hypertension
-
Julius, S., Gudbrandsson, T., Jamerson, K. A., Tariq, S. S. and Andersson, O. (1991) The hemodynamic link between insulin resistance and hypertension. 9, pp. 983-986.
-
(1991)
, vol.9
, pp. 983-986
-
-
Julius, S.1
Gudbrandsson, T.2
Jamerson, K.A.3
Tariq, S.S.4
Andersson, O.5
-
26
-
-
33750314218
-
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
-
Aksnes, T. A., Reims, H., Gupta, S., Moan, A., Os, I. and Kjeldsen, S. E. (2006) Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. 20, pp. 860-866.
-
(2006)
, vol.20
, pp. 860-866
-
-
Aksnes, T.A.1
Reims, H.2
Gupta, S.3
Moan, A.4
Os, I.5
Kjeldsen, S.E.6
-
27
-
-
0031911742
-
Angiotensin II and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats
-
Carlsson, P-O., Berne, C. and Jansson, L. (1998) Angiotensin II and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats. 41, pp. 127-133.
-
(1998)
, vol.41
, pp. 127-133
-
-
Carlsson, P.-O.1
Berne, C.2
Jansson, L.3
-
28
-
-
0036840307
-
Angiotensin blockade prevents type 2 diabetes by formation of fat cells
-
Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S. and Luft, F. C. (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. 40, pp. 609-611.
-
(2002)
, vol.40
, pp. 609-611
-
-
Sharma, A.M.1
Janke, J.2
Gorzelniak, K.3
Engeli, S.4
Luft, F.C.5
-
29
-
-
33846294746
-
Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis
-
Elliott, W. J. and Meyer, P. M. (2007) Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. 369, pp. 201-207.
-
(2007)
, vol.369
, pp. 201-207
-
-
Elliott, W.J.1
Meyer, P.M.2
|